COMPUS Communiqué – Vol. 3, No. 15

December 7, 2007

In This Issue

Diabetes Management Topic Area

The Canadian Agency for Drugs and Technologies in Health (CADTH), through its Canadian Optimal Medication Prescribing and Utilization Service (COMPUS), will be producing a series of optimal therapy reports on the insulin analogues component of our diabetes management topic area. We are currently seeking your feedback on our economic report listed below and providing you with a final report on current utilization.

Economic Report

CADTH invites you to provide input on its draft report: Economic Evaluation of Insulin Analogues for the Treatment of Patients With Type 1 and Type 2 Diabetes Mellitus in Canada.

The objective of this economic assessment is to determine the cost-effectiveness of insulin analogues relative to human insulin in the management of individuals with type 1 and type 2 diabetes mellitus in Canada.

Call for Input

CADTH recognizes that stakeholder input is an important part of the COMPUS program. Your input will assist COMPUS and the COMPUS Expert Review Committee in making recommendations toward optimal prescribing of rapid-acting and long-acting insulin analogues.

We are interested in receiving your feedback on:

  • The accuracy of the data, analysis, interpretation, and reporting. Please indicate potential errors and make reference to the corresponding page number.
  • The methods used in this report. If you have concerns with either the development or application of the methods, please state them clearly and make reference to the corresponding page number.
  • The limitations included in this report. Please indicate any additional limitations that should be included.

Please send your feedback to compusfeedback@cadth.ca by December 21, 2007.

For additional information, please refer to our consultations page.

Current Utilization Report

Today, COMPUS released the Optimal Therapy Report - Insulin Utilization Report: Current Utilization of Insulin in Canada. The purpose of this report is to explore how human insulin and insulin analogues are currently used in Canada. This report is one of a series of COMPUS Optimal Therapy Reports on the insulin analogues component of our diabetes management topic area.

Rx for Change Web Cast: Invitation – Reminder Notice

If you haven’t already done so, please sign in to the web cast site here to attend the COMPUS Rx for Change Web Cast. Discover how this first-in-class tool can help you to find current research evidence to improve drug prescribing practice and use.

December 10, 2007
1:00 p.m. to 3:00 p.m. EST
Free of charge

Questions about the upcoming web cast can be forwarded to rxforchange@cadth.ca.

Season’s Greetings!

Thank you for your continued support this year. We value your input on the development of our products and services.

All of us at COMPUS wish you a safe and happy holiday season!

CADTH will be closed for the holidays from December 24, 2007 through to January 2, 2008.

Employment Opportunities

CADTH has many exciting job openings. The COMPUS Directorate is currently recruiting for:

  • Research Officer (permanent position)
  • Research Officer (one-year term position)

If you’re interested in joining our growing team of professionals, visit Careers/Job Listings.

Feedback

We welcome your feedback. Tell us what you think of the COMPUS Communiqué.